Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Market Cap	2.71M 2.36M 2.18M 2.05M 3.83M 255M 3.86M 25.92M 10.04M 126M 10.16M 9.94M 437M	P/E 2022	-0.25x	P/E 2023	-0.19x
Enterprise Value	12.83M 11.19M 10.34M 9.69M 18.15M 1.21B 18.3M 123M 47.59M 596M 48.14M 47.11M 2.07B	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

25-02-19	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
25-02-16	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
25-02-10	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
25-02-10	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
25-02-10	Avinger, Inc. Announces Executive Changes	CI
24-12-24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24-12-24	US Futures Tread Water Ahead of Holiday Break	MT
24-12-23	Iberdrola Completes Merger with Avangrid	MT
24-11-07	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-11-07	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
24-11-07	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
24-11-07	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
24-10-04	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

23-04-21	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
22-05-11	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
22-03-18	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
21-06-29	AVINGER : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

25-01-02	Avinger : Private Placement Form 8 K	PU
24-11-07	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
24-11-07	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
24-11-07	Avinger: Q3 Earnings Snapshot	AQ
24-10-25	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	2024-08-04

Avinger Inc Stock Nasdaq

Stocks

US0537341093

Advanced Medical Equipment & Technology

Valuation: Avinger Inc

Latest news : Avinger Inc

Analysts' recommendations: Avinger Inc

Press Releases: Avinger Inc

Quotes and Performance

Managers and Directors: Avinger Inc

Medical Imaging Systems

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVINGER INC	-3.55%	-6.61%	-	-	1.52M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-5.99%	-7.79%	-18.47%	-26.23%	12.55B
IRAY GROUP	-0.26%	+1.61%	+97.06%	+20.90%	5.28B
SONOSCAPE MEDICAL CORP.	-1.04%	+0.11%	-38.75%	-65.54%	1.21B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	+1.69%	+0.88%	-32.94%	-44.37%	1.19B
IRADIMED CORPORATION	+1.22%	-1.50%	+57.74%	+82.18%	1.18B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	-0.53%	+2.18%	-40.26%	-	950M
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	-5.27%	-1.25%	+198.30%	+190.67%	705M
CAPSOVISION, INC.	+1.69%	-8.07%	-	-	330M
FISCHER MEDICAL VENTURES LIMITED	-0.74%	+3.69%	-57.65%	+200.00%	250M
Average	-1.28%	-1.67%	+20.63%	+51.09%	2.63B
Weighted average by Cap.	-3.31%	-3.82%	+14.97%	-3.14%

	2022	2023
Net sales	8.27M 7.21M 6.67M 6.25M 11.71M 780M 11.8M 79.21M 30.69M 384M 31.05M 30.38M 1.33B	7.65M 6.67M 6.17M 5.78M 10.83M 722M 10.91M 73.26M 28.39M 355M 28.72M 28.1M 1.23B
Net income	-17.62M -15.37M -14.21M -13.32M -24.93M -1.66B -25.14M -169M -65.38M -818M -66.14M -64.72M -2.84B	-18.32M -15.97M -14.77M -13.85M -25.92M -1.73B -26.13M -175M -67.96M -851M -68.76M -67.28M -2.95B
Net Debt	1.76M 1.53M 1.42M 1.33M 2.48M 166M 2.5M 16.81M 6.51M 81.53M 6.59M 6.45M 283M	10.12M 8.82M 8.16M 7.65M 14.32M 954M 14.43M 96.89M 37.54M 470M 37.98M 37.17M 1.63B